Paromomycin: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - " w/ " to " with ") |
ClaireLewis (talk | contribs) |
||
| Line 32: | Line 32: | ||
*GI obstruction | *GI obstruction | ||
*caution if ulcerative colitis | *caution if ulcerative colitis | ||
*caution if inflammatory bowel | *caution if inflammatory bowel disease | ||
*caution if renal impairment | *caution if renal impairment | ||
Revision as of 01:22, 14 July 2016
Administration
- Type: Amebicide
- Dosage Forms: 250
- Routes of Administration: Oral
- Common Trade Names: Humatin
Adult Dosing
Intestinal amebiasis
- 25-35 mg/kg/day PO divided tid x5-10 days
- Give with food
Hepatic encephalopathy
- adjunct tx: 1000 mg PO qid x5-6 days
- Give with food
Pediatric Dosing
Intestinal amebiasis
- 25-35 mg/kg/day PO divided tid x5-10 days
Special Populations
- Poorly absorbed when given orally
- Use during pregnancy has limited data
Renal Dosing
- No change in dosing
Hepatic Dosing
- No change in dosing
Contraindications
- Allergy to class/drug
- GI obstruction
- caution if ulcerative colitis
- caution if inflammatory bowel disease
- caution if renal impairment
Adverse Reactions
Serious
- nephrotoxicity
- ototoxicity, auditory
- ototoxicity, vestibular
- neurotoxicity
- neuromuscular blockade
- malabsorption syndrome (prolonged use)
- superinfection (prolonged use)
- enterocolitis
Common
Pharmacology
- Half-life: Unknown
- Metabolism: CYP450
- Excretion: Feces
Mechanism of Action
Bactericidal and amebicidal. Paromomycin binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis; it suppresses urease producing bacteria, reducing ammonia absorption from gut
Comments
See Also
References
UpToDate, Epocrates
